News | March 14, 2023
Alpla and Inden pharma form joint venture
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
The company will be submitting the responses to US FDA observations within stipulated timeline
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
Marksans' OTC Famotidine Tablets USP are acid reducers
Time to combine innovation, access and technology to deliver positive patient outcomes
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
